Safety tolerability and acceptability of longacting injectable cabotegravir for HIV prevention in cisgender female adolescents HPTN 08401 a singlearm openlabel phase 2b trial

Abstract

Description

Keywords

Citation

WOS

Endorsement

Review

Supplemented By

Referenced By